Capecitabine Plus Concomitant Radiation Therapy Followed by Durvalumab as Preoperative Treatment in Rectal Cancer
Clinical trial NCT04083365 · UNKNOWN
Trial details
- NCT number
- NCT04083365
- Sponsor
- AUSL Romagna Rimini
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2022-11-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.